Scientists have made an unusual discovery that could help to identify patients who are up to two-and-a-half times more likely to respond to currently available cancer drugs.
Jan 29, 2024
0
91
A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease. The tool, described in a new paper published January 26, 2024, in Nature Genetics, ...
Jan 26, 2024
0
45
Experiments with rats conducted by researchers at São Paulo State University (UNESP) in Brazil increase our understanding of why descendants of women who were malnourished during pregnancy tend to face a higher risk of prostate ...
Jan 24, 2024
0
51
A new research paper titled "Systematic analysis of the prognostic value and immunological function of LTBR in human cancer" has been published in Aging.
Jan 23, 2024
0
0
Many people are wired to seek and respond to rewards. Your brain interprets food as rewarding when you are hungry and water as rewarding when you are thirsty. But addictive substances like alcohol and drugs of abuse can overwhelm ...
Jan 23, 2024
0
0
Cleft lip and palate are the most common craniofacial birth defects in humans, affecting more than 175,000 newborns around the world each year. Yet despite decades of research, it's still not known what causes most cases ...
Jan 23, 2024
0
32
Cornell researchers have taken an important step toward harnessing CRISPR gene editing in "targeted, safe and potent" cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of ...
Jan 22, 2024
0
0
Tumors constantly shed DNA from dying cells, which briefly circulates in the patient's bloodstream before it is quickly broken down. Many companies have created blood tests that can pick out this tumor DNA, potentially helping ...
Jan 18, 2024
0
13
In a study published in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting ...
Jan 18, 2024
0
21
A new research paper titled "ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines" has been published in Oncotarget.
Jan 17, 2024
0
0
